­ As part of the continuous process to strengthen the organisation for the ongoing industrialisation and growth of Circa, the board of directors announced that Dr. Steve Döring has been appointed as the next CEO of Circa Group AS. The engagement of Dr. Döring is part of a succession plan following Tony Duncan's enormous efforts in the CEO role for Circa in over a decade. Tony Duncan will continue in the CEO role up to the transition with Dr. Döring which is scheduled to take place early in Fourth Quarter 2023.

Dr. Döring succeeds Tony Duncan who is co-founder of Circa and has been serving as CEO since 2006. During his time as CEO, Circa has developed from an Australian development initiative into a well-established, Euronext Growth listed, renewable chemicals company with a well-known brand internationally and strong growth ambitions. Following the hand-over of the CEO role, Circa will propose to the shareholders to elect Tony Duncan to the board of directors of Circa to continue his engagement for the development of the company.